Health - Medicine - Page 13

When the coronavirus epidemic began - it was only a few weeks ago and now seems centuries ago - doctors felt relatively confident, believing they knew who they were dealing with. Early medical reports suggested that the coronavirus appeared to be a standard respiratory virus, although it was not a common respiratory virus.

Since its appearance, the coronavirus responsible for Covid-19 has been the subject of an avalanche of scientific studies and research. More than 50,000 articles have already appeared in medical journals in just four months. Whole battalions of scientists, researchers and doctors from all countries are totally focused on the issue.

Despite the health red alert, President Donald Trump carried out during the night of Tuesday to Wednesday, April 15 his threat to cut off supplies to the World Health Organization (WHO), accusing it of "mismanagement" and "cover-up" in the coronavirus pandemic that started in China in late April.

A joint project conducted by four Finnish research organisations studied the transport and spread of coronavirus by air. Preliminary results indicate that aerosol particles carrying the virus may remain in the air longer than originally thought. It is therefore important to avoid

Professor Jean-Paul Moatti is an important voice in public health. He is Professor of Health Economics and former President of the Institut de Recherche pour le Développement (IRD). He chose the prestigious medical journal The Lancet to launch, in a short but scathing article, an analysis

It would be inconsistent to criticise now public authorities which, if only as a precautionary measure, could have included the possibility of a major health crisis in their forecasts. Apparently nothing prepared us for Covid-19 because no one believed in it. We learn a lot from those moments of suffering, of concern...

Public Health France makes available indicators for monitoring the COVID-19 epidemic by department, in order to follow the day-to-day evolution of hospitalisations in our regions and monitor the intensity of the epidemic. UP' offers you the graphs of Public Health France, revealing a national epidemic with variable geography. From

Epidemiological studies suggest that the world's oldest vaccine, the BCG used against tuberculosis, may reduce the risk of coronavirus infection as well as the risk of severe forms of Covid-19 disease. Professor Camille Locht, director of INSERM research at the Pasteur Institute in Lille, France, is the author of this study.

The United States has taken the option of having hundreds of millions of doses of vaccine manufactured, even before clinical trials have begun. They want to be ready for the market before others are. A risk in the form of a poker strike.

British American Tobacco, the manufacturer of cigarette brands such as Lucky Strike, Dunhill, Rothmans and Benson & Hedges, said a potential vaccine against coronavirus was being developed from tobacco plants. According to the firm, tobacco plants cannot, by their nature, be used to produce a vaccine,

A coalition of scientists, physicians, policy makers, ... has been formed to accelerate research on the prevention and treatment of VIDOC-19 in low- and middle-income countries. A challenge of unparalleled magnitude, particularly in terms of the ethics of research in the context of a health emergency

This Breton startup, Hemarina, has developed a molecule derived from a marine worm to transport oxygen in the blood. For Dr. Franck Zal, who made this discovery, it is a "molecular respirator" that could replace the artificial respirators that are sorely lacking for treating

Since the beginning of the coronavirus pandemic, the statistics have been consistent: the vast majority of children and young people under the age of 18 are either spared the disease or develop asymptomatic or mild forms. As the pandemic increases around the world,

The coronavirus pandemic is generating intense research activity around the world. Scientists are working to better understand and respond to the new virus. They are aided by the astronomical amounts of data accumulated day after day and freely shared by all of

Individuals with Covid-19 show a wide variety of symptoms, ranging from a complete absence of clinical signs to critical conditions such as acute respiratory distress syndrome. However, patients' condition evolves over time, sometimes unexpectedly or even abruptly, which complicates management.

According to Jean-François Toussaint, professor of physiology at the University of Paris, the epidemic peak would have occurred on Saturday in Italy. The curve of acceleration of the daily number of new deaths and the curve of acceleration of the daily number of deaths indicate a very clear inflection. Taking into account the respective evolution of the Italian curves

The names of these promising drugs to treat COVID-19 patients are beginning to become known to the public: Remdesivir, Ritonavir, Lopinavir and of course the most talked about, Chloroquine. These four promising treatments will be the subject of a major global study by the World Health Organization.

The COVID-19 pandemic is forcing our society to make choices of a magnitude and intensity whose consequences cannot yet be measured. While it is certainly justified to base decisions on the expertise of scientists, the crucial trade-offs are a political responsibility. In the area of public health, they constitute a

Bad news is piling up day after day about the global evolution of the coronavirus. Confinements are taking hold in the daily lives of hundreds of millions of people on every continent. Everybody's lives have changed in a matter of handfuls of days. Priorities have been turned upside down and everyone is faced with

How many deaths will the coronavirus cause? No one is yet able to answer this question, but in the worst-case scenario, it could number in the millions around the world, warn experts, who therefore stress the importance of measures such as containment. Time is running out in the face of a